Skip to content
Nonprofiteer
← LOUISIANA INDEPENDENT PHARMACIES ASSOCIATION INC

Form 990 for tax year 2025

Filed by LOUISIANA INDEPENDENT PHARMACIES ASSOCIATION INC.

Totals

Total revenue
$1,177,943
Total expenses
$1,268,005
Contributions and grants received
$1,042,116
Grants paid
$0
Program service revenue
$0
Investment income
$135,827
Other revenue
$0
Total assets, end of year
$4,264,198
Total liabilities, end of year
$318,218
Net assets or fund balances, end of year
$3,945,980
Program services expenses (Part IX)
not reported
Management and general expenses
not reported
Fundraising expenses
not reported
Program service expenses (Part III)
not reported

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1b , Membership dues

    $992,116

  • 1f , All other contributions, gifts and grants

    $50,000

  • 3 , Investment income

    total $89,670 · related or exempt $89,670

  • 7a , Gross sales of assets other than inventory

    securities $46,157

  • 7b , Less cost or other basis and sales expenses

    securities $0

  • 7c , Gain or loss

    securities $46,157

  • 7d , Net gain or loss

    total $46,157 · related or exempt $46,157

Functional expenses

Part IX, the statement of functional expenses.

  • 5 , Compensation of officers, directors and key employees

    total $150,000

  • 7 , Other salaries and wages

    total $328,417

  • 11a , Fees: management

    total $180,000

  • 11b , Fees: legal

    total $257,650

  • 11f , Fees: investment management

    total $28,956

  • 11g , Fees: other

    total $49,532

  • 12 , Advertising and promotion

    total $18,995

  • 16 , Occupancy

    total $18,066

  • 19 , Conferences, conventions and meetings

    total $49,258

  • 23 , Insurance

    total $15,950

  • 24a , Other expenses: Membership Dues

    total $131,031

  • 24b , Other expenses: Reimbursables

    total $30,007

  • 24c , Other expenses: Meals and Entertainment

    total $5,384

  • 24d , Other expenses: Proxy Taxes

    total $3,697

  • 24e , All other expenses

    total $1,062

Balance sheet

Part X, book values.

  • 1 , Cash, non-interest-bearing

    beginning of year $239,500 · end of year $89,145

  • 10a , Land, buildings and equipment: cost or other basis

    $13,796

  • 10b , Land, buildings and equipment: accumulated depreciation

    $7,222

  • 10c , Land, buildings and equipment, net

    beginning of year $6,430 · end of year $6,574

  • 13 , Investments: program-related

    beginning of year $3,566,916 · end of year $4,168,479

  • 25 , Other liabilities

    beginning of year $100,279 · end of year $318,218

  • 27 , Net assets without donor restrictions

    beginning of year -$184,838 · end of year $48,575

  • 28 , Net assets with donor restrictions

    beginning of year $3,897,405 · end of year $3,897,405

Mission and programs · 2025

Mission

We are dedicated to the continuing growth and prosperity of independent community pharmacy, representing the professional and proprietary interests of community pharmacists throughout Louisiana. We work to rigorously uphold the right of free enterprise, and are devoted to ensuring our members have the right to compete in a free and fair marketplace.

  • LIPA has an annual membership drive led by the CEO and the Executive Committee. Goals for the membership are set each year by the Board of Directors.

  • The newsletters of the Louisiana Independent Pharmacies Association provides a basis for communal support and interaction of all Louisiana member independent pharmacies. It also serves as an educational resource.

  • LIPA has established a mentoring program for pharmacy students to educate them on issues that will affect their business.

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • F Randal Johnson

    President & CEO

    Total calculated
    $150,000
    From this org
    $0
    From related orgs
    $0
    Other
    $150,000
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $0
    Bonus
    $0
    Other
    $0
    Deferred
    $150,000
    Nontaxable benefits
    $0
    Filer's total
    $150,000
  • TJ Woodard Pharm D

    Director

    Total calculated
    $0
    Hours/week
    0
  • Myles Stelly

    Director

    Total calculated
    $0
    Hours/week
    0
  • David Osborn RPH

    Director

    Total calculated
    $0
    Hours/week
    2
  • Diane Milano RPH

    Director

    Total calculated
    $0
    Hours/week
    0
  • Charlie Jones RPH

    Director

    Total calculated
    $0
    Hours/week
    0
  • Richard Andy Solieau RPH

    Director

    Total calculated
    $0
    Hours/week
    0
  • Kenny Wilson RPH

    Director

    Total calculated
    $0
    Hours/week
    2
  • Pat Boggs RPH

    Director

    Total calculated
    $0
    Hours/week
    2
  • Greg Poret RPH

    Director

    Total calculated
    $0
    Hours/week
    0
  • Nick Lebas RPH

    Director

    Total calculated
    $0
    Hours/week
    0
  • Allen Cassidy RPH

    Director

    Total calculated
    $0
    Hours/week
    2
  • Robert Rock

    Director

    Total calculated
    $0
    Hours/week
    0
  • Butch Ray

    Director

    Total calculated
    $0
    Hours/week
    0
  • Ray Glasgow

    Director

    Total calculated
    $0
    Hours/week
    0
  • Kim Wixson

    Director

    Total calculated
    $0
    Hours/week
    0

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement

The filer's explanations (Part III)

Part I, Line 3
The process to determine compensation for the organization's CEO, Executive Director, or top management official is reviewed by the Executive Committee and goes through Board approval.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2025
Filed
9 July 2026
IRS schema version
2025v4.2
Source object
202601909349301625

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.